Elevated serum creatine kinase activity in adolescent psychiatric inpatients on admission

International Clinical Psychopharmacology

Volumn 13, Issue 6, 1998, Pages 269-272

  Blumensohn, Rachel ^a   Yoran Hegesh, Roni ^a   Golubchik, Pavel ^a   Mester, Roberto ^a   Fluhr, Haya ^a   Hermesh, Haggai ^a   Weizman, Abraham ^b,c  

^a NESS ZIONA MENTAL HEALTH CENTER   (Israel)

^b GEHA MENTAL HEALTH CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Creatine kinase; Neuroleptics; Psychiatric disorders

Indexed keywords

CREATINE KINASE; NEUROLEPTIC AGENT;

ACUTE PSYCHOSIS; ADOLESCENT; AFFECTIVE NEUROSIS; ARTICLE; CREATINE KINASE BLOOD LEVEL; DISEASE SEVERITY; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DEFICIENCY; MENTAL PATIENT; NEUROLEPTIC MALIGNANT SYNDROME; PRIORITY JOURNAL; RESTLESSNESS; SCHIZOPHRENIA;

EID: 0031794539     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-199811000-00005     Document Type: Article

References (15)

1. Cohen JJ, Johnson W, Carparulo BK, Young JB (1976): Creatine phosphokinase levels in children with severe developmental disturbances. Arch Gen Psychiatry 33:683-686.
2. Crayton JW, Meltzer HY (1976): Serum creatine phospho-kinase activity in psychiatrically hospitalized children. Arch Gen Psychiatry 33:679-681.
3. Engel WR, Meltzer HY (1970): Histochemieal abnormalities of skeletal muscle in patients with acute psychosis: part I. Science 168:273-275.
4. ICD-9-CM International Classification of Diseases (1980): Clinical Modification, Vol. 1. 2nd ed. Geneva, Switzerland: WHO.
5. Manor I, Hermesh H, Valevski A, Benjamin Y, Munitz H, Weizman A (1998): Recurrence pattern of serum creatine phosphokinase levels in repeated acute psychosis. Biol Psychiatry 43:288-292.
6. Meltzer HY (1976): Neuromuscular dysfunction in schizophrenia. Schizophrenia Bull 2:106-135.
7. Meltzer H, Elkun L, Moline R (1969): Serum enzyme changes in newly admitted psychiatric patients. Arch Gen Psychiatty 21:731-738.
8. Meltzer HY, Nankin R, Raftery J (1971): Serum creatine phosphokinase activity in newly admitted psychiatric patients. Part II. Arch Gen Psychiatry 24:568-572.
9. Meltzer HY, Belmaker R, Wyatt RJ, Pollin W, Cohen S (1976): Serum creatine phosphokinase (CPN) activity in monozygotic twins discordant for schizophrenia: heritability of serum CPK activity. Compr Psychiatry 17:469-475.
10. Meltzer HY, Ross-Stanton J, Schlessinger S (1980): Mean serum creatine kinase activity in patients with functional psychoses. Arch Gen Psychiatry 37:650-655.
11. O'Dwyer A, Sheppard NP (1993): The role of creatine kinase in the diagnosis of neuroleptic malignant syndrome. Psychol Med 23:323-326.
12. Soni SD (1976): Serum creative phosphokinase in acute psychosis. Br J Psychiatry 128:181-183.
13. Swartz CM, Breen KJ (1990): Multiple muscle enzyme release with psychiatric illness. J Nerv Ment Dis 178:755-759.
14. Szasz G, Gruber W, Bernt E (1976): Kinetic determination of creatine kinase activity. Clin Chem 22:650-656.
15. Taylor JR (1977): Massive creatine phosphokinase elevation with acute psychosis. Biol Psychiatry 12:589-592.